Eagle Pharmaceuticals's market cap is currently $19.48M. The company's EPS TTM is $; its P/E ratio is ―; Eagle Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Income Statement
Total Revenue	$ 316.61M	$ 171.55M	$ 187.80M	$ 195.89M	$ 213.31M
Gross Profit	$ 221.67M	$ 129.37M	$ 142.34M	$ 135.00M	$ 151.40M
Operating Income	$ 80.96M	$ -2.91M	$ 25.25M	$ 21.82M	$ 36.62M
EBITDA	$ 77.50M	$ 2.77M	$ 30.02M	$ 28.18M	$ 40.44M
Net Income	$ 35.64M	$ -8.63M	$ 11.99M	$ 14.31M	$ 31.90M
Balance Sheet
Cash & Short-Term Investments	$ 55.32M	$ 97.66M	$ 103.16M	$ 109.78M	$ 78.79M
Total Assets	$ 406.16M	$ 253.73M	$ 253.19M	$ 254.55M	$ 238.60M
Total Debt	$ 67.79M	$ 25.61M	$ 37.09M	$ 38.56M	$ 44.41M
Net Debt	$ 12.47M	$ -72.05M	$ -66.06M	$ -71.22M	$ -34.39M
Total Liabilities	$ 172.60M	$ 77.28M	$ 67.18M	$ 75.38M	$ 77.84M
Stockholders' Equity	$ 233.56M	$ 176.45M	$ 186.01M	$ 179.17M	$ 160.76M
Cash Flow
Free Cash Flow	$ 50.52M	$ 27.90M	$ 48.75M	$ 55.21M	$ 52.25M
Operating Cash Flow	$ 50.70M	$ 28.22M	$ 49.50M	$ 55.99M	$ 52.38M
Investing Cash Flow	$ -86.83M	$ -5.32M	$ -18.25M	$ -777.00K	$ -133.00K
Financing Cash Flow	$ -6.21M	$ -28.39M	$ -37.87M	$ -24.23M	$ -88.12M

Currency in USD

Eagle Pharmaceuticals Earnings and Revenue History

Income Statement >

Eagle Pharmaceuticals Debt to Assets

Balance Sheet >

Eagle Pharmaceuticals Cash Flow

Cash Flow >

Eagle Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing